As the pace of the COVID-19 vaccine rollout accelerates, the roles of various players continue to evolve among government, public companies, and private entities. Pharmaceutical and supply manufacturers, healthcare service providers, educators, advertisers, transportation and logistics providers, and many others are constantly assessing and reassessing the changing dynamic for their industries and organizations. But what opportunities, regulatory considerations, and legal obstacles still lie ahead?
From digital passports to data privacy to supply chain management, the rollout of the COVID-19 vaccine and modified vaccines will continue to generate novel challenges, particularly as the delivery system moves to a more private sector model. Join us for a series of webinars that will explore the legal and regulatory issues arising for businesses that have become increasingly central to rolling out vaccines in the United States and around the globe.
CLE credit in CA, IL, NY, PA, TX, and VA is currently pending approval. Credit in CT, FL, and NJ is pending approval (via reciprocity).